Letter to the Editor on "COVID-19 Infection in Men on Testosterone Replacement Therapy".
作者信息
MacDonald Scott, Wambier Carlos Gustavo
机构信息
Alpert Medical School of Brown University, Providence, RI, USA.
Alpert Medical School of Brown University, Providence, RI, USA.
出版信息
J Sex Med. 2021 Jun;18(6):1141-1142. doi: 10.1016/j.jsxm.2021.03.003. Epub 2021 Mar 19.
Abstract
摘要
相似文献
1
Letter to the Editor on "COVID-19 Infection in Men on Testosterone Replacement Therapy".致编辑的信：关于“接受睾酮替代疗法的男性感染新冠病毒”
J Sex Med. 2021 Jun;18(6):1141-1142. doi: 10.1016/j.jsxm.2021.03.003. Epub 2021 Mar 19.
2
COVID-19 Infection in Men on Testosterone Replacement Therapy.COVID-19 感染与接受睾丸素替代疗法的男性
J Sex Med. 2021 Jan;18(1):215-218. doi: 10.1016/j.jsxm.2020.09.013. Epub 2020 Oct 9.
3
Testosterone administration in older men.睾酮治疗老年男性。
Endocrinol Metab Clin North Am. 2013 Jun;42(2):271-86. doi: 10.1016/j.ecl.2013.02.011. Epub 2013 Mar 22.
4
Hypogonadism in elderly men--what to do until the evidence comes.老年男性性腺功能减退——在有确凿证据之前该如何应对。
N Engl J Med. 2004 Jan 29;350(5):440-2. doi: 10.1056/NEJMp038207.
5
Association between cholesterol gallstones and testosterone replacement therapy in a patient with primary hypogonadism.原发性性腺功能减退患者胆固醇胆结石与睾酮替代疗法之间的关联。
Rev Gastroenterol Mex (Engl Ed). 2018 Apr-Jun;83(2):205-207. doi: 10.1016/j.rgmx.2017.09.005. Epub 2018 Apr 12.
6
Clinical hypogonadism and androgen replacement therapy: an overview.临床性腺功能减退与雄激素替代疗法：概述
Urol Nurs. 2006 Aug;26(4):253-9, 269; quiz 260.
7
MY APPROACH to testosterone replacement in older men.我对老年男性睾酮替代疗法的方法。
Trends Cardiovasc Med. 2016 Apr;26(3):295-6. doi: 10.1016/j.tcm.2015.06.009. Epub 2016 Jan 18.
8
Risks of testosterone-replacement therapy and recommendations for monitoring.睾酮替代疗法的风险及监测建议。
N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251.
9
[Testosterone replacement therapy for hypogonadism in men with prostate cancer].[睾酮替代疗法用于前列腺癌男性性腺功能减退]
Ugeskr Laeger. 2017 Feb 27;179(9).
10
A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.氯米酚与睾酮替代治疗性腺功能减退男性继发性红细胞增多症的比较：一项多机构研究。
J Urol. 2017 Apr;197(4):1127-1131. doi: 10.1016/j.juro.2016.10.068. Epub 2016 Oct 27.
本文引用的文献
1
Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical).非那雄胺早期抗雄激素治疗可减少男性 COVID-19 患者的病毒脱落、炎症反应和缓解时间：一项随机、双盲、安慰剂对照干预试验（EAT-DUTA AndroCoV 试验 - 生化研究）
Cureus. 2021 Feb 1;13(2):e13047. doi: 10.7759/cureus.13047.
2
Potential risk for developing severe COVID-19 disease among anabolic steroid users.使用合成代谢类固醇的人群患严重 COVID-19 疾病的潜在风险。
BMJ Case Rep. 2021 Feb 26;14(2):e241572. doi: 10.1136/bcr-2021-241572.
3
Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial.恩杂鲁胺显著加速轻至中度新冠肺炎患者的病毒清除并缩短临床缓解时间：一项随机、双盲、安慰剂对照试验的结果
Cureus. 2021 Feb 22;13(2):e13492. doi: 10.7759/cureus.13492.
4
COVID-19 Infection in Men on Testosterone Replacement Therapy.COVID-19 感染与接受睾丸素替代疗法的男性
J Sex Med. 2021 Jan;18(1):215-218. doi: 10.1016/j.jsxm.2020.09.013. Epub 2020 Oct 9.
5
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.5-α还原酶抑制剂与雄激素性脱发男性新冠症状发作频率降低有关。
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e243-e246. doi: 10.1111/jdv.17021. Epub 2020 Nov 22.
6
The impact of sex and gender on immunotherapy outcomes.性别对免疫治疗结果的影响。
Biol Sex Differ. 2020 May 4;11(1):24. doi: 10.1186/s13293-020-00301-y.
7
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
Zotero 插件